Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
4.89M
-
Shares change
-
-2.97M
-
Total reported value, excl. options
-
$8.37M
-
Value change
-
-$5.31M
-
Put/Call ratio
-
3.2
-
Number of buys
-
21
-
Number of sells
-
-23
-
Price
-
$1.71
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2015
54 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q2 2015.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.89M shares
of 29.5M outstanding shares and own 16.56% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (909K shares), FMR LLC (532K shares), PANAGORA ASSET MANAGEMENT INC (415K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (414K shares), SABBY MANAGEMENT, LLC (295K shares), Frigate Ventures LP (284K shares), BlackRock Institutional Trust Company, N.A. (277K shares), Iguana Healthcare Management, LLC (250K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (197K shares), and GROUP ONE TRADING, L.P. (194K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.